Annual Operating Expenses
$29.16 M
-$5.48 M-15.83%
31 December 2023
Summary:
Tempest Therapeutics annual total operating expenses is currently $29.16 million, with the most recent change of -$5.48 million (-15.83%) on 31 December 2023. During the last 3 years, it has risen by +$2.17 million (+8.04%). TPST annual operating expenses is now -15.83% below its all-time high of $34.64 million, reached on 31 December 2022.TPST Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$10.55 M
+$969.00 K+10.11%
30 September 2024
Summary:
Tempest Therapeutics quarterly total operating expenses is currently $10.55 million, with the most recent change of +$969.00 thousand (+10.11%) on 30 September 2024. Over the past year, it has increased by +$3.04 million (+40.42%). TPST quarterly operating expenses is now at all-time high.TPST Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +40.4% |
3 y3 years | +8.0% | +43.8% |
5 y5 years | - | - |
TPST Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -15.8% | +8.0% | at high | +60.1% |
5 y | 5 years | -15.8% | +51.1% | at high | +144.1% |
alltime | all time | -15.8% | +51.1% | at high | +144.1% |
Tempest Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $10.55 M(+10.1%) |
June 2024 | - | $9.58 M(+20.2%) |
Mar 2024 | - | $7.97 M(+6.1%) |
Dec 2023 | $29.16 M(-15.8%) | $7.51 M(+14.0%) |
Sept 2023 | - | $6.59 M(-11.8%) |
June 2023 | - | $7.47 M(-1.5%) |
Mar 2023 | - | $7.58 M(-15.1%) |
Dec 2022 | $34.64 M | $8.93 M(+1.9%) |
Sept 2022 | - | $8.77 M(-0.0%) |
Date | Annual | Quarterly |
---|---|---|
June 2022 | - | $8.77 M(+7.5%) |
Mar 2022 | - | $8.16 M(+11.2%) |
Dec 2021 | $26.99 M(+39.8%) | $7.34 M(-5.1%) |
Sept 2021 | - | $7.74 M(+14.0%) |
June 2021 | - | $6.79 M(+32.3%) |
Mar 2021 | - | $5.13 M(+18.6%) |
Dec 2020 | $19.30 M | $4.32 M(-20.4%) |
Sept 2020 | - | $5.43 M(+3.7%) |
June 2020 | - | $5.24 M |
FAQ
- What is Tempest Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly operating expenses year-on-year change?
What is Tempest Therapeutics annual total operating expenses?
The current annual operating expenses of TPST is $29.16 M
What is the all time high annual operating expenses for Tempest Therapeutics?
Tempest Therapeutics all-time high annual total operating expenses is $34.64 M
What is Tempest Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of TPST is $10.55 M
What is the all time high quarterly operating expenses for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly total operating expenses is $10.55 M
What is Tempest Therapeutics quarterly operating expenses year-on-year change?
Over the past year, TPST quarterly total operating expenses has changed by +$3.04 M (+40.42%)